期刊文献+

联合检测生化标志物在急性冠脉综合症早期危险分层中的意义 被引量:26

Value of biochemical marker detection in risk stratification in patients with acute coronary syndrome
下载PDF
导出
摘要 目的初步探讨联合监测多生化标志物在急性冠脉综合症住院患者危险分层中的意义。方法连续入选因胸闷、胸痛为主诉入院的患者264例(男180例,女84例),年龄64(55~69)岁。根据患者病情发展及变化,决定是否24h内行冠状动脉造影术(CAG)。将所有患者分为急诊CAG组和择期CAG组两组。每位患者在入院即刻抽取静脉血,分别检测氨基末端脑钠肽前体(NT-pro-BNP),超敏C反应蛋白(hs-CRP),髓过氧化物酶(MPO),单核细胞趋化蛋白-1(MCP-1),细胞间粘附分子(sICAM-1),可溶性CD40配体(sCD40L),基质金属蛋白酶9(MMP-9),白细胞介素6(IL-6),白细胞介素27(IL-27)及肌酸激酶同工酶(CK-MB)。结果①急诊CAG组和择期CAG组之间NT-proBNP,hs-CRP,MPO,sCD40L,MMP-9差异有统计学意义(P<0.05);②采用Logistic逐步回归,筛选出有统计学意义的生化标记物为NT-proBNP,hs-CRP,MPO,IL-27和CK-MB,建立预测ACS患者危险分层模型,进一步刀切法进行效果预测,并绘制ROC曲线,结果显示,ROC曲线下面积为98.1,提示该模型对ACS患者入院病情变化或发展具有较高的预测价值。结论联合检测生化标志物有助于对急性冠脉综合症住院患者进行早期危险分层。 Objective To assess the value of biochemical marker detection in risk stratification in hospitalized patients with acute coronary syndrome (ACS). Methods A total of 264 consecutive patients (180 male and 84 female patients) admitted for complaint of chest tightness or/and pain were evaluated for a decision of coronary angiography (CAG) within 24 h after admission. The patients were divided into two groups to receive emergency or elective CAG. The venous blood samples were taken from the patient immediately after admission for detection of amino-terminal pro-brain natriuretic peptide (NT-pro-BNP), high-sensitivity C-reactive protein (hs-CRP), myeloperoxidase (MPO), monocyte chemoattractant protein 1 (MCP-1), intercellular adhesion molecule (sICAM-1), soluble CD40 ligand (sCD40L), matrix metalloproteinase 9 (MMP-9), interleukin-6 (IL-6), interleukin 27 (IL-27) and creatine kinase isoenzyme (CK-MB) were detected. Results No significant differences in NT-proBNP, hs-CRP, MPO, sCD40L, and MMP-9 were found between emergency CAG group and elective CAG group (P0.05). Logistic regression identified significant differences in NT-proBNP, hs-CRP, MPO, IL-27 and CK-MB between the two groups, and a predictive model for risk stratification of ACS was established using these biomarkers. The ROC curves of this predictive model showed an area under the curve of 98.1, suggesting a high predictive value of this model in assessment of the changes or progression of ACS. Conclusion Combined detection of the biochemical markers can be helpful for risk stratification of the hospitalized patients with ACS early after admission.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第5期1015-1019,共5页 Journal of Southern Medical University
基金 广州市科技计划项目任务书(2008Z1-E451) 广东省自然科学基金(9151051501000056)
关键词 生化标志物 急性冠脉综合症 危险分层 biochemical markers acute coronary syndrome risk stratification
  • 相关文献

参考文献27

  • 1Lucas AL, Korol R, Pepine CJ. Inflammation in atherosclerosis: some thoughts about the acute coronary syndromes [J ]. Circulation, 2006, 113: e728-e732.
  • 2Apple FS, Pearce LA, Chung A, et al. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome [J]. Clin Chem, 2007, 53: 874-81.
  • 3Apple FS, Wu AH, Mair J, et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome [J ]. Clin Chem, 2005, 51: 810-24.
  • 4Thim T, Hagensen MK, Bentzon JF, et al. From vulnerable plaque to atherothrombosis[J ]. J Intern Med, 2008, 263(5): 506-16.
  • 5Bassand JP, Harem CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes[J]. Eur Heart J, 2007, 28: 1598-660.
  • 6TIM/IIIB investigators effects of tissue plasrninogen activator and comparison of early Invasive and conservative st rategies in unstable angina and Non-Q-wave myocardial infraction. Results of the TIMI IIIB[J]. Circulation, 1994, 89: 1545-56.
  • 7Spacek R,Widimsky P, Straka Z, et al. Value of first day angiography/ angioplasty in evolving non-ST segment elevation myocardial infarction: an open multieenter randomized trial. The V INO Study [J]. Eur Heart J, 2002, 23: 230-8.
  • 8Tousoulis D, Kampoli AM, Stefanadi E, et al. New biochemical markers in acute coronary syndrome[J]. Cttrr Med Chem, 2008, 15: 1288-96.
  • 9Brerman ML, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain [J]. N Engl J Med, 2003, 349: 1595-604.
  • 10Martin M, Oliver D, Reinhold M, et al. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes [ J ]. Clin Chim Acta, 2008, 393:103-9.

二级参考文献18

  • 1Anderson NL, Anderson NG. Proteome and proteomics: new technologies, new concepts and new words. Electrophoresis, 1998,19:1853-1861.
  • 2Unlu M, Morgan M, Minden J, et al. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis, 1997, 18:2071-2077.
  • 3Layh SG, Podtelejnikov A, Mann M, et al. Proteins complexed to the P1 adhesion of mycoplasma pneumoniae. Microbiology, 2000,146:741-747.
  • 4Dayal B, Ertel NH. ProteinChip technology: a new and facile method for the identification and measurement of high-density lipoproteins apoA-I and apoA-II and their glycosylated products in patients with diabetes and cardiovascular disease. J Proteome Res,
  • 5McDonough JL, Neverova I, Van-Eyk JE, et al. Proteomic analysis of human biopsy samples by single two-dimensional electrophoresis: Coomassie, silver, mass spectrometry, and Western blotting. Proteomics, 2002, 2: 978-987.
  • 6Neverova Irina; Van-Eyk JE. Application of reversed phase high performance liquid chromatography for subproteomic analysis of cardiac muscle. Proteomics, 2002, 2: 22-31.
  • 7Taylor SW, Fahy E, Zhang B, et al. Characterization of the human heart mitochondrial proteome. Nat Biotechnol, 2003, 21: 281-286.
  • 8Huber LA, Pfaller K, Vietor I, et al. Organelle proteomics: implications for subcellular fractionation in proteomics. Circ Res, 2003, 92: 962-968.
  • 9Brookes PS, Pinner A, Ramachandran A, et al. High throughput two-dimensional blue-native electrophoresis: a tool for functional proteomics of mitochondria and signaling complexes. Proteomics, 2002, 2: 969-977.
  • 10Taylor SW, Warnock DE, Glenn GM, et al. An alternative strategy to determine the mitochondrial proteome using sucrose gradient fractionation and 1D PAGE on highly purified human heart mitochondria. J Proteome Res, 2002, 1: 451-458.

共引文献3

同被引文献212

引证文献26

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部